Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.

Tsuchiya N, Narita S, Inoue T, Saito M, Numakura K, Huang M, Hatakeyama S, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.

BMC Cancer. 2013 Mar 25;13:150. doi: 10.1186/1471-2407-13-150.

2.

Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.

Cheng I, Stram DO, Penney KL, Pike M, Le Marchand L, Kolonel LN, Hirschhorn J, Altshuler D, Henderson BE, Freedman ML.

J Natl Cancer Inst. 2006 Jan 18;98(2):123-34.

PMID:
16418515
3.

Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.

Tsuchiya N, Wang L, Suzuki H, Segawa T, Fukuda H, Narita S, Shimbo M, Kamoto T, Mitsumori K, Ichikawa T, Ogawa O, Nakamura A, Habuchi T.

J Clin Oncol. 2006 May 1;24(13):1982-9.

PMID:
16648498
4.

Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.

Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH, Hallmans G, Bälter K, Adami HO, Grönberg H, Stattin P, Kaaks R.

J Clin Endocrinol Metab. 2007 Dec;92(12):4820-6. Epub 2007 Oct 2.

PMID:
17911177
5.

ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.

Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, Mirowski M.

Int J Colorectal Dis. 2009 Aug;24(8):895-905. doi: 10.1007/s00384-009-0724-0. Epub 2009 May 5.

PMID:
19415305
6.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

7.

Association of caspases with an increased prostate cancer risk in north Indian population.

Mittal RD, Mittal T, Singh AK, Mandal RK.

DNA Cell Biol. 2012 Jan;31(1):67-73. doi: 10.1089/dna.2011.1285. Epub 2011 Jun 13.

PMID:
21668377
8.

CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia.

Tsuchiya N, Wang L, Horikawa Y, Inoue T, Kakinuma H, Matsuura S, Sato K, Ogawa O, Kato T, Habuchi T.

Int J Oncol. 2005 Jan;26(1):225-31.

PMID:
15586244
9.

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk.

Eklund CM, Tammela TL, Schleutker J, Hurme M.

Br J Cancer. 2009 Jun 16;100(12):1846-51. doi: 10.1038/sj.bjc.6605081. Epub 2009 May 12.

10.

Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.

Liu J, Song B, Bai X, Liu W, Li Z, Wang J, Zheng Y, Wang Z.

BMC Cancer. 2010 Aug 24;10:456. doi: 10.1186/1471-2407-10-456.

11.

A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.

Wong HL, Delellis K, Probst-Hensch N, Koh WP, Van Den Berg D, Lee HP, Yu MC, Ingles SA.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):144-51.

12.

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.

Cao Y, Lindström S, Schumacher F, Stevens VL, Albanes D, Berndt S, Boeing H, Bueno-de-Mesquita HB, Canzian F, Chamosa S, Chanock SJ, Diver WR, Gapstur SM, Gaziano JM, Giovannucci EL, Haiman CA, Henderson B, Johansson M, Le Marchand L, Palli D, Rosner B, Siddiq A, Stampfer M, Stram DO, Tamimi R, Travis RC, Trichopoulos D, Willett WC, Yeager M, Kraft P, Hsing AW, Pollak M, Lin X, Ma J.

J Natl Cancer Inst. 2014 Jun;106(6):dju085. Erratum in: J Natl Cancer Inst. 2014 Jun;106(6):dju194.

13.

Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.

Kanda S, Tsuchiya N, Narita S, Inoue T, Huang M, Chiba S, Akihama S, Saito M, Numakura K, Tsuruta H, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.

Int J Cancer. 2015 Jan 1;136(1):74-82. doi: 10.1002/ijc.28952. Epub 2014 May 20.

14.

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.

Muendlein A, Lang AH, Geller-Rhomberg S, Winder T, Gasser K, Drexel H, Decker T, Mueller-Holzner E, Chamson M, Marth C, Hubalek M.

J Cancer Res Clin Oncol. 2013 Mar;139(3):491-8. doi: 10.1007/s00432-012-1355-3. Epub 2012 Nov 23.

PMID:
23180020
15.

Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Langsenlehner T, Thurner EM, Renner W, Gerger A, Kapp KS, Langsenlehner U.

Strahlenther Onkol. 2014 Apr;190(4):364-9. doi: 10.1007/s00066-013-0503-2. Epub 2014 Jan 18.

PMID:
24435801
16.
17.

Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.

Langsenlehner T, Renner W, Gerger A, Hofmann G, Thurner EM, Kapp KS, Langsenlehner U.

Strahlenther Onkol. 2011 Dec;187(12):784-91. doi: 10.1007/s00066-011-1106-4. Epub 2011 Nov 17.

PMID:
22105769
18.

Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.

Rivadeneira F, van Meurs JB, Kant J, Zillikens MC, Stolk L, Beck TJ, Arp P, Schuit SC, Hofman A, Houwing-Duistermaat JJ, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2006 Sep;21(9):1443-56.

19.

Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.

Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H.

Exp Biol Med (Maywood). 2008 Dec;233(12):1608-14. doi: 10.3181/0803-RM-110. Epub 2008 Oct 10.

PMID:
18849534
20.

Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.

Pechlivanis S, Wagner K, Chang-Claude J, Hoffmeister M, Brenner H, Försti A.

Cancer Detect Prev. 2007;31(5):408-16. Epub 2007 Nov 26.

PMID:
18031946

Supplemental Content

Support Center